GAMMAGARD Trademark

Trademark Overview

On Monday, June 13, 1983, a trademark application was filed for GAMMAGARD with the United States Patent and Trademark Office. The USPTO has given the GAMMAGARD trademark a serial number of 73430125. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, February 20, 2015. This trademark is owned by Baxter Travenol Laboratories, Inc.. The GAMMAGARD trademark is filed in the Pharmaceutical Products category with the following description:

Immunoglobulin for Intramuscular and Intravenous Administration to Humans
gammagard

General Information

Serial Number73430125
Word MarkGAMMAGARD
Filing DateMonday, June 13, 1983
Status800 - REGISTERED AND RENEWED
Status DateFriday, February 20, 2015
Registration Number1314247
Registration DateTuesday, January 15, 1985
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 29, 1984

Trademark Statements

Goods and ServicesImmunoglobulin for Intramuscular and Intravenous Administration to Humans
Pseudo MarkGAMMA GUARD

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateTuesday, January 15, 1985
Primary Code005
First Use Anywhere DateWednesday, April 27, 1983
First Use In Commerce DateWednesday, April 27, 1983

Trademark Owner History

Party NameBAXALTA INCORPORATED
Party Type41 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBANNOCKBURN, IL 60015
Party NameBaxter International, Inc.
Party Type40 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter Travenol Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter Travenol Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter Travenol Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 15, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 15, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 6, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 6, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 10, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 20, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, February 20, 2015REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, February 20, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, February 20, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 4, 2015TEAS SECTION 8 & 9 RECEIVED
Friday, May 16, 2008CASE FILE IN TICRS
Tuesday, December 4, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 26, 2005REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, January 26, 2005REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 20, 2004REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, October 20, 2004REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, October 20, 2004TEAS SECTION 8 & 9 RECEIVED
Monday, February 11, 1991REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 5, 1990REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, January 15, 1985REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 1984PUBLISHED FOR OPPOSITION
Wednesday, April 4, 1984NOTICE OF PUBLICATION
Wednesday, February 22, 1984APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, February 5, 1984CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 30, 1984NON-FINAL ACTION MAILED
Thursday, December 29, 1983ASSIGNED TO EXAMINER

Related Keywords

gammagard humans administration intravenous intramuscular immunoglobulin